CONTACT US | REPORT A FRAUD

CASE UPDATES

CLASS CERTIFIED IN SALLIE MAE SECURITIES LITIGATION

A federal judge has formally certified the case on behalf of Sallie Mae investors as a class action.

TRANSVAGINAL MESH INVESTIGATION

Girard Gibbs is investigating cases of women suffering health complications after receiving transvaginal mesh implants.

DISH CLASS ACTION LAWSUIT SETTLEMENT

Notice of a proposed DISH lawsuit settlement sent to class members. Claim forms are available here.

ACOSTA CLASS CERTIFIED BY COURT

Girard Gibbs' collective action lawsuit against Acosta Sales has been granted conditional certification.

RAINTREE VACATION CLUB SPECIAL ASSESSMENT LAWSUIT

A proposed nationwide settlement has been reached in the Raintree Vacation Club Special Assessment class action lawsuit.

MF GLOBAL SECURED NOTES INVESTIGATION

Girard Gibbs investigates MF Global secured notes following company's recent stock decline.

ACTOS LAWSUIT FILED

Girard Gibbs files Actos Lawsuit against Takeda Pharmaceuticals.

ACTOS LAWYERS

Girard Gibbs represents people who got bladder cancer after taking Actos.

GIRARD GIBBS ATTORNEYS SELECTED TO BEST LAWYERS OF 2012

Daniel Girard and Eric Gibbs have been selcted to the Best Lawyers of America 2012.

$80 MILLION SETTLEMENT REACHED WITH SECURITIES AMERICA, AMERIPRISE

More information about the Provident and Medical Capital Class Action Settlement.

WORLDMARK/ WYNDHAM TIME SHARE CLASS ACTION LAWSUIT SETTLED

Read the Wyndham Class Action Notice
More information about the Wyndham class action lawsuit.

Current Consumer Cases

Current Securities Cases

Raymond James Financial (NYSE: RJF)
Class Action Investigation

Did you sustain losses investing in the common stock of
Raymond James Financial, Inc. (NYSE: RJF)?

Girard Gibbs LLP is investigating Raymond James Financial, Inc. for potential violations of federal securities laws. Investors who purchased shares of the company's common stock (NYSE: RJF) between April 22, 2008 and April 14, 2009 may be affected.

A securities class action lawsuit was filed against Raymond James and certain of its trustees and officers in federal court in New York. The plaintiffs allege that Raymond James was repeatedly represented as having conservative management principles and avoiding risky assets associated with subprime mortgages when, in fact, the company had failed to disclose the substantial credit risks associated with its subsidiary's residential and commerical loan portfolios. Further, that the defendants failed to set aside adequate reserves for the losses that they knew, or should have known, were forthcoming.

On April 14, 2009, Raymond James revealed that results for the second quarter would be well below the analysts' estimates and that its residential and commerical portfolios would require higher loss reserves that had been anticipated, and that its loan loss provisions had tripled from the previous quarter. Following this announcement, Raymond James stock fell to $2.50 per share , or 13.48%, a 50% decline from its class period high.

If you wish to discuss your rights as an investor in Raymond James Financial common stock (NYSE: RJF), please fill out the information sheet to the right or contact us toll free at (866) 981-4800. If you purchased or otherwise acquired shares of Raymond James common stock, you may, no later than August 10, 2009, move the Court to serve as lead plaintiff of the class. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation.

Why Girard Gibbs LLP?

Girard Gibbs is a national litigation firm specializing in securities litigation, consumer class actions and complex business litigation. Girard Gibbs' managing partner Daniel Girard was voted one of Northern California's Super Lawyers in 2007, 2008, and 2009 by Law & Politics, recognizing him as one of the top 5-percent of attorneys practicing in Northern California.





WANT MORE INFORMATION ABOUT THE RAYMOND JAMES FINANCIAL CLASS ACTION INVESTIGATION?

Please fill out the form below, or call toll-free (866) 981-4800 for a confidential consultation.

Name:
Telephone:
E-Mail:
Message [please include, to the extent that you know 1) Date of purchase; 2) Broker you purchased through; 3) Number of shares held]:

I would like to receive updates concerning this lawsuit.

Your use of this web site, or sending of email to Girard Gibbs LLP, does not, by itself, create an attorney-client relationship between you and Girard Gibbs LLP.

Privacy Policy: Girard Gibbs maintains the privacy of your message. We do not transfer your personal information, including your email address, to any third party. Information entered in the form will be used solely for informational purposes to assist in our case investigations.